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To determine the prognostic value of cortisol, Dehydroepiandrosterone (DHEA) and Dehy-
droepiandrosterone-sulfate (DHEAS), together with their ratios (cortisol/DHEA and cortisol/
DHEAS), as independent predictors of mortality in septic patients.
Methods
Prospective cohort study of 139 consecutive patients with a diagnosis of severe sepsis or
septic shock. Adrenal hormones were determined within the first 24 hours of the septic pro-
cess. To determine and compare the predictive ability of each marker for the risk of unfavor-
able evolution (in-hospital, 28-day and 90-day mortality), ROC (Receiver Operating
Characteristic) curves were constructed and the area under the curve (AUC) was deter-
mined. As measures of association, adjusted odds ratios (OR) with their 95% confidence
intervals (95%CI) were estimated by unconditional logistic regression. Cortisol, DHEA and
DHEAS results were compared to lactate, CRP, SOFA and APACHE II Scores.
Results
Cortisol showed the best predictive ability, with AUCs of 0.758, 0.759 and 0.705 for in-hospi-
tal mortality, and 28-day and 90-day mortality, respectively; whereas AUCs for 28 days mor-
tality for SOFA and APACHE II scores, and other biomarkers studied, such as Lactate or
CRP, were 0.644, 0.618, 0.643 and 0.647, respectively. Associations between high cortisol
levels (>17.5 μg/dL) and mortality were strong and statistically significant for in-hospital and
28-day mortality: adjusted ORs 10.13 and 9.45 respectively, and lower for long term mortal-
ity (90 days): adjusted OR 4.26 (95% CI 1.34–13.56), p trend 0.014. Regarding adrenal
androgens, only positive associations were obtained for DHEAS and most of these positive
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associations did not yield statistical significance. Regarding Cortisol/DHEA and cortisol/
DHEAS ratios, they did not improve the predictive ability of cortisol. The only exception was
the cortisol/DHEAS ratio, which was the best predictor of mortality at 90 days (AUC 0.737),
adjusted OR for highest cortisol/DHEAS ratio values 6.33 (95%CI 1.77–22.60), p trend
0.002.
Conclusion
Basal cortisol measured within the first 24 hours of the septic process was the best prognos-
tic factor for in-hospital and 28-day mortality, even superior to the Sequential Organ Failure
Assessment (SOFA) or Acute Physiology and Chronic Health Evaluation II (APACHE II)
scores. The cortisol/DHEAS ratio was an independent predictor of long-term mortality.
Introduction
Sepsis is an organic dysfunction caused by an unregulated host response to infection [1]. Cur-
rently, it is one of the main causes of admission to an intensive care unit, with a mortality rate
of between 25–30%, rising to 40–50% in the case of septic shock [2]. Early identification of
patients at a higher risk of death is a major challenge. Despite the existence of multiple risk
scales, none of these are sufficiently accurate to predict mortality with adequate sensitivity and
specificity [3]. The incorporation of new biomarkers is a fundamental task that can improve
the predictive ability and the therapeutic intervention in septic patients.
The activation of the hypothalamic-pituitary-adrenal (HPA) axis is an essential component
of the general adaptation to illness [4]. During sepsis, an up-regulation of cortisol and adrenal
androgens, such as DHEA, has been described, but not of DHEAS [5]. The role of cortisol and
adrenal androgens as prognostic factors in the septic patient has shown conflicting results [6–
11]. On the other hand, given their immunomodulatory counteracting actions, it has been pro-
posed that the increase in the cortisol/DHEA and cortisol/DHEAS ratios may represent novel
prognostic markers in septic patients [5,7,10].
The aims of this study were to assess the prognostic value of a single determination of corti-
sol, DHEA, DHEAS and their ratios on Intensive Care Unit (ICU) admission in severe sepsis
and septic shock patients, as well as to compare this with the prognostic value of a single deter-
mination of classical biomarkers, such as arterial lactate or C-reactive protein (CRP) on ICU
admission, and to evaluate whether the addition of the same to SOFA could improve the prog-
nostic accuracy of this severity score.
Material and methods
Study population
In a prospective cohort study conducted in the ICU of the Sierrallana Hospital in Torrelavega
(Spain), we analyzed serum samples from 139 consecutive patients included in the first 24
hours of severe sepsis or septic shock diagnosis, between November 2011 and December 2017.
The inclusion criteria consisted of patients aged 18 years or older and admitted to the ICU
within 24 hours after diagnosis of severe sepsis or septic shock, according to the 2001 Interna-
tional Sepsis Definitions Conference [12].
The exclusion Criteria were: patients who received corticosteroid treatment or who were
treated with drugs that affect adrenal function within a six month period prior to admission;
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patients with known HPA axis disease or adrenal insufficiency (AI); patients with acute liver
failure or chronic stage Child-Pugh B or C liver disease.
All patients included in the study were treated according to the recommendations of the
Surviving Sepsis Campaign 2012 guidelines [13].
Serum hormone measurements
Basal cortisol, DHEA and DHEAS levels were determined between 8:00 and 09:00 a.m. All
samples were processed within one hour of extraction.
For the determination of total cortisol, the chemiluminescent immunoassay of microparti-
cles ARCHITECT (Abbot, Wiesbaden, Germany), was used, which has a sensitivity� 1 (μg/
dL) and a specificity of 0–0.9%, except for fludrocortisone (36.6%) and prednisolone (12.3%).
The levels of DHEA were quantified in serum using DRG-specific Radioimmunoassay
(DRG Instruments, Marburg, Germany). Sensitivity: 0.06 ng/ml. Specificity: Very low cross
reactivity<0.001% with DHEAS, isoandrosterone, androstenedione and other related steroids.
Intra-assay reproducibility of the method is <3.8% and interassay reproducibility is <8.6%.
DHEAS levels were quantified in serum by competitive solid phase chemiluminescent
enzyme immunoassay in a Siemens IMMULITE 2000 (Siemens Health Care Diagnostics,
Gwynedd, UK). Sensitivity: 10 g/dl. Specificity: Cross reactivity <0.1% with related steroids.
Intra-assay reproducibility of the method is 7.1% and interassay reproducibility is 9.8%.
Additional measures
The APACHE II and SOFA scores were determined and samples were extracted for the deter-
mination of CRP, arterial lactate and other analyses, according to the routine in place at the
unit.
More information at http://dx.doi.org/10.17504/protocols.io.ymxfu7n.
Ethical approval and consent to participate
The study was conducted according to the guidelines of the Declaration of Helsinki and was
approved by the Clinical Research Ethics Committee of Cantabria (CEIC: 2015–001), requir-
ing signed informed consent from each patient or the responsible family member. This study
was observational, and data for each patient were anonymous.
Statistical analysis
For categorical variables, proportions were estimated using the Pearson chi-square test for
comparisons or, alternatively, the exact Fisher test. For continuous variables, mean values with
their standard deviation (SD) were estimated. The Student’s t-test or Mann-Whitney tests
were used to analyze the relationship between quantitative variables and dichotomous categor-
ical variables. The condition of normality was previously checked using the Shapiro-Wilk test.
To determine and compare the predictive capabilities of each biomarker and severity scores
on the risk of unfavorable evolution (death), ROC (Receiver Operating Characteristic) curves
were constructed and the area under the curve (AUC) was determined. Data were analyzed
globally and restricted to patients with low albumin levels (<2.5 g/dl).
To estimate the strength of associations, the biomarkers and severity scores were divided
into dichotomous variables (low versus high values) according to the median, and adjusted
odds ratios (OR) with their 95% confidence intervals (95%CI) for mortality were calculated
using unconditional logistic regression. The following potential confounders were pre-estab-
lished to be included in the models: age (as continuous variable), sex, SOFA score (as a
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continuous variable) and diagnosis of severe sepsis or septic shock. In addition, exposure-
response trends (biological gradient) were estimated using a logistic regression model with all
potential confounders, categorizing the prognostic factors according to tertiles. The category
below was the reference category except for DHEA and DHEAS.
The statistical analysis was performed using SPSS statistical software package version 22.0
and Stata 13.0 for Windows. The level of statistical significance was set at 0.05 and all tests
were two-tailed.
Results
Baseline characteristics are shown in Table 1. A total of 139 patients were included (61.9%,
N = 86 men; 38.1%, N = 53 women). The mean age was 67.15±14.27 years and 33.1% had sep-
tic shock at admission. Twenty-five (18%) patients died in hospital, twenty-three (16.5%) at 28
days and thirty-one (21.6%) at 90 days. Deaths among female and older patients were more
frequent and women were on average 4.89 years older than men, 95%CI (0.01 to 9.77),
p = 0.049 (data not shown in tables).
Among the prognostic factors studied, the best rate of prediction of in-hospital mortality
was cortisol in both the total sample and in patients with albumin less than 2.5 g/dL. (AUCs
0.758 and 0.772) (Table 2). On the other hand, the predictive ability of adrenal androgens
(DHEA and DHEAS) was lower regarding cortisol, AUCs 0.460 and 0.556 (Table 2). The ROC
curve for SOFA, APACHE II, lactate and CRP yielded AUCs of 0.636, 0.561, 0.639 and 0.682,
respectively (S1 Table). Adding cortisol to the logistic model increased the predictive capacity
in relation to SOFA for in-hospital mortality: SOFA alone (AUC 0.636), SOFA + Cortisol
(AUC 0.759) (S1 Table).
Regarding 28-day mortality, the AUC value for Cortisol was 0.759, higher than DHEA and
DHEAS (AUCs 0.459 and 0.565) (S2 Table). SOFA and APACHE II AUCs were 0.644 and
0.618; and Lactate and CPR AUCs were 0.643 and 0.647, respectively (S3 Table).
Regarding 90-day mortality, similar AUC values were obtained: 0.705 for Cortisol (S4
Table), and 0.614, 0.612, 0.611 and 0.677, SOFA, APACHE II, Lactate and CPR respectively
(S5 Table). The predictive ability of adrenal androgens for both DHEA and DHEAS was again
lower when compared to cortisol during this period (S4 Table)
Tables 3, 4 and 5 show the strength of associations (OR) and exposure-response trends
(Biological gradient) between adrenal function biomarkers in relation to in-hospital mortality
and mortality at 28 and 90 days, respectively. In the regression analysis, the basal cortisol also
revealed the strongest association when values were dichotomized according to the median, in
relation to in-hospital, 28-day and 90-day mortality, with adjusted ORs of 3.80, 3.24 and 2.37,
respectively (Tables 3, 4 and 5). For in-hospital mortality, a significant exposure-response
trend was obtained: adjusted OR at the highest tertile (ORa T3) 10.13, 95%CI 2.05–50.04, p
trend 0.003 (Table 3). A similar association was found for 28-day mortality: ORa T3 9.45, 95%
CI 1.87–47.72, p trend 0.005 (Table 4). In relation to 90-day mortality, the association was
lower, although preserving the exposure-response pattern: ORa T3 4.26, 95%CI 1.34–13.56, p
trend 0.014 (Table 5).
Among the severity scores SOFA and APACHE II, crude positive non-significant associa-
tions (the higher the score, the higher risk of mortality) were obtained: for in-hospital mortal-
ity, crude OR at the highest tertile (OR T3) of APACHE II 1.79, 95%CI 0.58–5.51, p trend
0.319; OR T3 of SOFA 2.10, 95%CI 0.68–6.48, p trend 0.203 (S6 Table). However, after adjust-
ing for age, gender, and severe sepsis or septic shock, these positive associations disappeared
for APACHE II and diminished for SOFA (S6 Table). The same patterns were observed for
mortality at 28 and 90 days (S7 and S8 Tables).
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Regarding Lactate and CRP, the ORa T3 of lactate was 1.26, 95%CI 0.37–4.24, p trend
0.712; and the ORa T3 of CRP was 2.70, 95%CI 0.85–8.56, p trend was 0.074 in relation to in-
hospital mortality (S6 Table). Similar associations were obtained for mortality at 28 and 90
days (S7 and S8 Tables).
Regarding adrenal androgens, DHEA and DHEAS, only positive associations were obtained
for DHEAS in any of the studied mortality periods. Most of these positive associations did not
yield statistical significance (Tables 3–5).
Regarding Cortisol/DHEA and cortisol/DHEAS ratios, these ratios were also associated
with statistically significant increases in mortality risk and exposure response patterns.
Table 1. Baseline characteristics, in relation to in-hospital mortality.
Variables Total Survivors Non survivors p
(n = 139) (n = 114) (n = 25)
Age, mean (SD) 67.15 (14.27) 65.96 (14.54) 72.60 (11.79) 0.035
Sex male (M), female (F), n(%) M: 86 (61.9) M:75 (65,8) M:11 (44) 0.042
F: 53 (38.1) F:39 (34,2) F:14 (56)
Charlson comorbidity index, median (IQR) 1.00 (0.00–3.00) 1.00 (1.00–3.00) 2.00 (0.50–2.50) 0.272
Severe sepsis, n (%) 93 (66.9) 79 (69.3) 14 (56) 0.201
Septic shock, n (%) 46 (33.1) 35 (30.7) 11 (44)
Source of infection 0.148
Abdominal, n (%) 51 (36.7) 40 (35.1) 11 (44)
Lung, n (%) 35 (25.2) 27 (23.7) 8 (32)
Urogenital, n (%) 32 (23) 31 (27.2) 1 (4)
Primary septicemia, n (%) 11 (7.9) 9 (7.9) 2 (8)
Others, n (%) 10 (7.2) 7 (6.1) 3 (12)
APACHE II score, median (IQR) 18.00 (12.00–22.00) 17.50 (11.00–21.00) 18.00 (14.50–23.00) 0.342
SOFA, median (IQR) 6.00 (4.00–7.00) 6.00 (3.00–7.00) 7.00 (4.00–9.00) 0.032
Unit of hospitalization 0.008
Medical, n (%) 102 (73.4) 89 (78.1) 13 (52)
Surgical, n (%) 37 (26.6) 25 (21.9) 12 (48)
CRP (mg/L), median (IQR) 206.50 (133.80–280.70) 185.15 (125.10–263.87) 304.40 (156.50–369.90) 0.005
Arterial lactate (mmol/L),
median (IQR)
1.60 (1.20–2.40) 1.50 (1.17–2.25) 1.80 (1.35–5.10) 0.029
ACTH (pgr/mL), median (IQR) 19.00 (13.00–40.00) 18.00 (11.50–34.50) 21.00 (14.00–53.00) 0.248
Cortisol (μg/dL), median (IQR) 17.50 (13.10–26.00) 16.25 (12.72–22.85) 27.50 (17.45–41.45) <0.001
DHEA (ngr/mL), median(IQR) 2.70 (1.80–4.40) 2.70 (1.80–4.15) 2.80 (1.90–4.90) 0.530
DHEAS (μg/dL), median (IQR) 54.30 (22.70–112.00) 56.00 (22.15–118.25) 38.80 (26.75–67.10) 0.384
Cortisol/DHEA, (μg�dl-1/ng�ml-1) median (IQR) 6.29 (4.28–9.61) 5.82 (4.07–8.96) 8.44 (5.31–14.09) 0.014
Cortisol/DHEAS, (ng/ng),
median (IQR)
0.33 (0.17–0.79) 0.27 (0.16–0.68) 0.69 (0.34–1.09) 0.003
Mechanical ventilation (No), n (%) 114 (82) 99 (86.8) 15 (60) 0.002
Mechanical ventilation (Yes), n (%) 25 (18) 15 (86.8) 10 (40)
Mechanical ventilation time days, mean (SD) 8.68 (7.59) 5.85 (4.96) 11.75 (8.88) 0.050
Vasopressors (No), n (%) 81 (58,3) 68 (59.6) 13 (52) 0.482
Vasopressors (Yes), n (%) 58 (41.7) 46 (40.4) 12 (48)
Vasopressors time days,
mean (SD)
3.33 (4.46) 2.61 (2.14) 5.06 (7.41) 0.198
ICU length of stay, days mean (SD) 8.57 (20.05) 7.75 (21.56) 11.42 (13.38) 0.371
Hospital length of stay,
days mean (SD)
22.76 (24.40) 23.00 (26.36) 21.90 (16.14) 0.826
https://doi.org/10.1371/journal.pone.0214312.t001
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However, these associations were lower than associations for cortisol alone in relation to “in-
hospital and at 28-day mortality” (Tables 3 and 4). On the contrary, for 90-day mortality, the
associations for both ratios were greater than those for cortisol alone: ORa T3 of cortisol/
DHEA ratio 5.71, 95%CI 1.63–19.99, p trend 0.004; ORa T3 of cortisol/DHEAS ratio 6.33, 95%
CI 1.77–22.60, p trend 0.002 (Table 5).
Discussion
Adrenal hormones play a key role in adaptation to stress. Our results support that basal corti-
sol, measured in the first 24 hours after diagnosis of sepsis, is an important independent prog-
nostic factor for both short (in-hospital) and medium term mortality (28 days). However, the
cortisol/DHEAS ratio would have a higher predictive capacity to cortisol alone for long-term
mortality (90 days).
The associations between cortisol levels above the median (>17.6 μg/dl) and the increase of
in-hospital and 28-day mortality remained after adjusting for the main confounding variables,
such as age, sex, SOFA scale value and severe sepsis or septic shock status, supporting the inde-
pendence of this association. In addition, an exposure-response pattern was obtained, where
higher levels revealed a greater risk of mortality. Patients with high levels (third tertile) had
about a ten-fold risk of in-hospital 28-day mortality compared with patients with lower levels
of cortisol. This suggests causality, as both the independence of the association, and the
strength and exposure-response pattern, are Bradford Hill’s criteria for causality [14]. Like-
wise, the predictive capacity of a single cortisol determination, in relation to the AUC deter-
mined by the ROC curves, was superior to the more complex severity scores (SOFA and
APACHE II), and to the classically used biomarkers (Lactate and CRP), to predict the risk of
mortality in the septic patient. The predictive capacity in relation to SOFA, increased by add-
ing cortisol to the logistic models. Thus, cortisol alone could be a useful biomarker to predict
in-hospital and 28-day mortality with a greater predictive capacity than the SOFA and
APACHE II scores and other biomarkers studied (lactate and CRP).
Our results are consistent with those described by other authors who have identified an
association between elevated cortisol levels and an increased risk of mortality in septic patients
[5–10,15]. The septic process has a dynamic course in which a balance between the hyperim-
mune response and immunosuppression is essential [16]. Cortisol has known anti-inflamma-
tory and immunosuppressive actions, mostly triggered by its binding to a glucocorticoid
receptor (GR) [17]. Although the complications of sepsis have been associated with an uncon-
trolled inflammatory response, this hypothesis is largely derived from work on animal models.
In fact, the use of anti-inflammatory agents for the treatment of sepsis has not been shown to
be beneficial in humans and may even cause harmful effects if used during the hypoimmune
phase [18–20]. Therefore, an excessive increase in cortisol levels in the early stages of the septic
Table 2. Area under curve (AUC) for the adrenal function biomarkers in relation to in-hospital mortality, in the overall population and restricted to patients with
low albumin levels (<2.5 g/dl).
Adrenal Biomarkers Total Albumin <2.5 g/dl
AUC (95% CI) AUC (95% CI)
Cortisol (μg/dL) 0.758 0.658 0.857 0.772 0.67 0.875
DHEA (ng/ml) 0.460 0.335 0.585 0.461 0.324 0.598
DHEAS (μg/dL) 0.556 0.441 0.671 0.539 0.411 0.668
Cortisol/DHEA (μg�dl-1/ng�ml-1) 0.658 0.539 0.777 0.658 0.528 0.788
Cortisol/DHEAS (ng/ng) 0.689 0.583 0.796 0.672 0.552 0.792
https://doi.org/10.1371/journal.pone.0214312.t002
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process can destabilize the balance towards the hypoimmune state at an inappropriate time
and have a negative effect on prognosis [21]. Moreover, it has recently been described how the
use of glucocorticoids can decrease the ability of cortisol to bind to GR, which can lead to
increased peripheral resistance to its actions [22].
Table 3. Crude and adjusted odds ratios for adrenal function biomarkers on the risk of in-hospital mortality (all-causes).
Survivors Non survivors
Adrenal biomarkers Cut-of points N = 114 N = 25 OR (95% CI) ORa (95% CI)
Cortisol (μg/dL) (Median)
Low (reference) < = 17.5 65 6 1.00 — 1.00 —
High 17.6+ 49 19 4.20 1.56 11.30 3.80 1.34 10.79
Cortisol (μg/dL) (Tertiles)
Low (reference) < = 14.4 46 2 1.00 — 1.00 —
Medium 14.5–22.2 37 8 4.97 0.99 24.85 6.86 1.25 37.52
High 22.3+ 31 15 11.13 2.38 52.13 10.13 2.05 50.04
p linear trend p = 0.001 p = 0.003
DHEA (ng/ml)(Median)
High (reference) 2.8+ 53 13 1 — 1 —
Low < = 2.7 61 12 0.80 0.22 1.88 0.88 0.34 2.25
DHEA (ng/ml)(Tertiles)
High (reference) 3.5+ 34 10 1 — 1 —
Medium 2.3–3.4 37 7 0.64 0.22 1.88 0.57 0.18 1.83
Low < = 2.2 43 8 0.63 0.23 1.78 0.72 0.23 2.23
p linear trend p = 0.385 p = 0.569
DHEAS (μg/dl)(Median)
High (reference) 54.4+ 60 9 1 — 1 —
Low < = 54.3 54 16 1.98 0.81 4.84 1.65 0.63 4.31
DHEAS (μg/dl)(Tertiles)
High (reference) 79.1+ 41 5 1 — 1 —
Medium 33.7–79.0 35 11 2.58 0.82 8.13 1.81 0.52 6.33
Low < = 33.6 38 9 1.94 0.60 6.31 1.63 0.46 5.76
p linear trend p = 0.315 p = 0.499
Cortisol/DHEA, (μg�dl-1/ng�ml-1) (Median)
Low (reference) < = 6.296 62 8 1.00 — 1.00 —
High 6.297+ 52 17 2.53 1.01 6.34 2.72 1.02 7.29
Cortisol/DHEA (μg�dl-1/ng�ml-1) (Tertiles)
Low (reference) < = 5.093 42 4 1.00 — 1.00 —
Medium 5.094–8.292 39 8 2.15 0.60 7.72 2.31 0.59 9.12
High 8.293+ 33 13 4.14 1.23 13.87 4.47 1.18 16.86
p linear trend p = 0.017 p = 0.023
Cortisol/DHEAS (ng/ng) (Median)
Low (reference) < = 0.326 64 6 1.00 — 1.00 —
High 0.327+ 50 19 4.05 1.51 10.90 3.59 1.26 10.28
Cortisol /DHEAS (ng/ng) (Tertiles)
Low (reference) < = 0.202 43 4 1.00 — 1.00 —
Medium 0.203–0.608 38 8 2.26 0.63 8.12 1.96 0.51 7.54
High 0.609+ 33 13 4.23 1.26 14.19 3.21 0.88 11.73
p linear trend p = 0.016 p = 0.072
ORa: Odds ratio adjusted by age, sex, SOFA score and diagnosis of severe sepsis or septic shock.
https://doi.org/10.1371/journal.pone.0214312.t003
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In contrast to cortisol, adrenal androgens have immunostimulatory actions [23]. In our
study, adrenal androgens had a lower prognostic capacity for in-hospital and 28-day mortality.
Predictive capacity was superior for DHEAS in relation to DHEA. The predictive capacity of
the cortisol/DHEA and cortisol/DHEAS ratios was also not greater than that of cortisol alone
Table 4. Crude and adjusted odds ratios for adrenal function biomarkers on the risk of 28-day mortality (all-causes).
Survivors Non survivors
Adrenal biomarkers Cut-off points N = 116 N = 23 OR (95% CI) ORa (95% CI)
Cortisol (μg/dL) (Median)
Low (reference) < = 17.5 65 6 1.00 — — 1.00 — —
High 17.6+ 51 17 3.61 1.33 9.82 3.24 1.12 9.40
Cortisol (μg/dL) (Tertiles)
Low (reference) < = 14.4 46 2 1.00 — — 1.00 — —
Medium 14.5–22.2 38 7 4.24 0.83 21.61 6.48 1.13 37.05
High 22.3+ 32 14 10.06 2.14 47.35 9.45 1.87 47.72
p linear trend p = 0.001 p = 0.005
DHEA (ng/ml)(Median)
High (reference) 2.8+ 54 12 1.00 — — 1.00 — —
Low < = 2.7 62 11 0.80 0.33 1.95 0.89 0.33 2.38
DHEA (ng/ml)(Tertiles)
High (reference) 3.5+ 34 10 1.00 — — 1,00 — —
Medium 2.3–3.4 39 5 0.44 0.14 1.40 0.35 0.10 1.27
Low < = 2.2 43 8 0.63 0.22 1.78 0.72 0.23 2.30
p linear trend p = 0.384 p = 0.575
DHEAS (μg/dl)(Median)
High (reference) 54.4+ 61 8 1.00 — — 1.00 — —
Low < = 54.3 55 15 2.08 0.82 5.28 1.70 0.62 4.64
DHEAS (μg/dl)(Tertiles)
High (reference) 79.1+ 42 4 1.00 — — 1.00 — —
Medium 33.7–79.0 35 11 3.30 0.96 11.28 2.16 0.56 8.25
Low < = 33.6 39 8 2.15 0.60 7.72 1.73 0.44 6.80
p linear trend p = 0.287 p = 0.513
Cortisol/DHEA, (μg�dl-1/ng�ml-1) (Median)
Low (reference) < = 6.296 62 8 1.00 — — 1.00 — —
High 6.297+ 54 15 2.15 0.85 5.47 2.40 0.87 6.63
Cortisol/DHEA (μg�dl-1/ng�ml-1) (Tertiles)
Low (reference) < = 5.093 43 3 1,00 — — 1.00 — —
Medium 5.094–8.292 39 8 2.94 0.73 11.87 3.74 0.81 17.3
High 8.293+ 34 12 5.06 1.32 19.37 6.40 1.41 29.01
p linear trend p = 0.015 p = 0.015
Cortisol/DHEAS (ng/ng) (Median)
Low (reference) < = 0.326 65 5 1.00 — — 1.00 — —
High 0.327+ 51 18 4.59 1.60 13.20 4.21 1.36 13.05
Cortisol /DHEAS (ng/ng) (Tertiles)
Low (reference) < = 0.202 44 3 1.00 — — 1.00 — —
Medium 0.203–0.608 38 8 3.09 0.76 12.47 2.81 0.64 12.38
High 0.609+ 34 12 5.18 1.35 19.81 3.98 0.95 16.72
p linear trend p = 0.013 p = 0.060
ORa: Odds ratio adjusted by age, sex, SOFA score and diagnosis of severe sepsis or septic shock.
https://doi.org/10.1371/journal.pone.0214312.t004
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for short and medium-term mortality. However, concerning long-term mortality, the role for
cortisol/adrenal androgens ratios could be greater, especially for the cortisol/DHEAS ratio,
since the area under the curve for this index (AUC 0.74) was greater than that of cortisol itself
(AUC 0.71).
Table 5. Crude and adjusted odds ratios for adrenal function biomarkers on the risk of 90-day mortality (all-causes).
Survivors Non survivors
Adrenal biomarkers Cut-off points 108 N = 31 OR (95% CI) ORa (95% CI)
Cortisol (μg/dL) (Median)
Low (reference) < = 17.5 61 10 1.00 — 1.00 —
High 17.6+ 47 21 2.73 1.17 6.34 2.37 0.97 5.82
Cortisol (μg/dL) (Tertiles)
Low (reference) < = 14.4 43 5 1.00 — 1.00 —
Medium 14.5–22.2 36 9 2.15 0.66 6.99 3.05 0.85 10.92
High 22.3+ 29 17 5.04 1.67 15.19 4.26 1.34 13.56
p linear trend p = 0.003 p = 0.014
DHEA (ng/ml)(Median)
High (reference) 2.8+ 51 15 1.00 — 1.00 —
Low < = 2.7 57 16 0.95 0.43 2.12 1.13 0.47 2.71
DHEA (ng/ml)(Tertiles)
High (reference) 3.5+ 33 11 1.00 — 1.00 —
Medium 2.3–3.4 36 8 0.67 0.24 1.86 0.63 0.21 1.92
Low < = 2.2 39 12 0.92 0.36 2.36 1.13 0.40 3.23
p linear trend p = 0.890 p = 0.786
DHEAS (μg/dl)(Median)
High (reference) 54.4+ 60 9 1.00 — 1.00 —
Low < = 54.3 48 22 3.06 1.29 7.25 2.71 1.07 6.85
DHEAS (μg/dl)(Tertiles)
High (reference) 79.1+ 41 5 1.00 — 1.00 —
Medium 33.7–79.0 34 12 2.89 0.93 9.03 2.05 0.60 7.04
Low < = 33.6 33 14 3.48 1.14 10.65 3.01 0.91 10.00
p linear trend p = 0.032 p = 0.072
Cortisol/DHEA, (μg�dl-1/ng�ml-1) (Median)
Low (reference) < = 6.296 60 10 1.00 — 1.00 —
High 6.297+ 48 21 2.63 1.13 6.10 2.84 1.14 7.09
Cortisol/DHEA (μg�dl-1/ng�ml-1) (Tertiles)
Low (reference) < = 5.093 41 5 1.00 — 1.00 —
Medium 5.094–8.292 38 9 1.94 0.60 6.31 2.13 0.59 7.72
High 8.293+ 29 17 4.81 1.59 14.51 5.71 1.63 19.99
p linear trend p = 0.004 p = 0.004
Cortisol/DHEAS (ng/ng) (Median)
Low (reference) < = 0.326 64 6 1.00 — 1.00 —
High 0.327+ 44 25 6.06 2.30 15.99 5.93 2.08 16.88
Cortisol /DHEAS (ng/ng) (Tertiles)
Low (reference) < = 0.202 43 4 1.00 — 1.00 —
Medium 0.203–0.608 38 8 2.26 0.63 8.12 2.10 0.55 8.07
High 0.609+ 27 19 7.57 2.32 24.64 6.33 1.77 22.60
p linear trend p = 0.000 p = 0.002
ORa: Odds ratio adjusted by age, sex, SOFA score and diagnosis of severe sepsis or septic shock.
https://doi.org/10.1371/journal.pone.0214312.t005
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Few studies have evaluated the role of adrenal androgens in sepsis. Mueller C et al., [7]
determined that the values of cortisol/DHEA and cortisol/DHEAS ratios increased signifi-
cantly in patients with more severe pneumonias. Marx C et al., [10] found lower levels of
DHEAS at the beginning and end of sepsis among the non survivors. Arlt et al., [5] reported a
dissociation between DHEA and DHEAS levels in septic patients and an increase in mortality
associated with increased cortisol/DHEA ratio values.
During sepsis there is an increase in cortisol levels especially in relation to a decrease in its
peripheral metabolism [24]. This prolonged sustained increase in cortisol can lead to inhibi-
tion of the HPA axis by negative feedback with the consequent risk of developing AI [25].
None of the tests used for the assessment of the integrity of the HPA axis is considered ade-
quate in the early stages of the septic process, as these rely on the determination of serum corti-
sol and levels of the same are significantly influenced by changes in peripheral metabolism.
DHEAS, the most abundant steroid hormone in the circulatory system, is almost entirely
secreted by the reticular area of the adrenal cortex under the stimulus of ACTH. For these rea-
sons, it has recently proven its usefulness as an indicator of the integrity of the HPA axis [26].
Our hypothesis is that DHEAS may be an appropriate tool for early diagnosis of septic patients
at high risk of developing AI. Elevation of the cortisol/DHEAS ratio may identify patients with
increased HPA axis suppression and prolonged loss of the trophic effect of ACTH on the adre-
nal glands, and thus increased long-term risk of AI. This may explain why the cortisol/DHEAS
ratio is a good predictor of long-term mortality in our study. Further prospective studies spe-
cifically designed to test this hypothesis would be necessary.
Our study has some limitations. First, we used the determination of total cortisol, whose
values are influenced by the levels of transport proteins. In our study, 77% of patients had an
albumin level of less than 2.5 (g/dl). However, the predictive ability of cortisol remained con-
stant in this group, supporting the validity of our results. Additionally, free cortisol analysis is
a laborious technique performed in very few specialized centers and would therefore, be diffi-
cult to apply in routine clinical practice. Another limitation is that we only performed a single
measurement. The changes in adrenal hormone values throughout the course of sepsis are well
known and, therefore, our results can be reproducible if extraction is performed within the
first 24 hours of the septic process. This study also presents important strengths such as its pro-
spective nature, and the thoroughness of the inclusion criteria with a comprehensive exclusion
of all patients who had received drugs that interfered with the HPA axis.
Conclusions
In septic patients, serum total cortisol determined at 8–9 a.m. within the first 24 hours of the
diagnosis, may be a useful biomarker for predicting in-hospital and 28-day mortality, with a
greater predictive ability than the SOFA and APACHE II scores and other biomarkers studied,
such as Lactate or CRP. The addition of adrenal androgens to perform the cortisol/androgens
ratio would not increase predictive ability and, therefore, its determination for mortality
restricted to in-hospital or 28-day periods does not seem clinically useful. Adrenal androgens,
especially DHEAS, may have a greater role in long-term mortality. In this case, the predictive
capacity of cortisol/DHEAS may be slightly higher than that of cortisol alone.
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